FindTrial
Sign In

Tthe treatment of malignant glaucoma by modified Transscleral cyclophotocoagulation

Application of low dose Transscleral cyclophotocoagulation in the treatment of malignant glaucoma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017960
Enrollment
Unknown
Registered
2018-08-24
Start date
2018-09-02
Completion date
Unknown
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant glaucoma

Interventions

Case series:Transscleral cyclophotocoagulation

Sponsors

The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with malignant glaucoma; 2. IOP > 21mmHg; 3. IOP can't reduce to normal and anterior chamber depth didn't deepen after using cycloplegic and IOP-lowering drugs.

Exclusion criteria

Exclusion criteria: 1. Patients with serious heart, brain, kidney, lung diseases, advanced cancer, poor controlled hypertension or blood glucose, and any other intolerance of ophthalmic surgery; 2. Patients with acute infectious inflammation of eyes, or with the risk of infection.

Design outcomes

Primary

MeasureTime frame
Intraocular pressure;adverse events;Anterior chamber depth;—

Secondary

MeasureTime frame
vision;—

Countries

China

Contacts

Public ContactYuan-Bo Liang

The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University

yuanboliang@126.com+86 0577-88053493

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026